B
BALAXI
Trading
₹527.95
0.00 (0.00%)
| Market Cap | 536 Cr | EPS | 15.9 | High | 529.55 | ||
| Stock P/E | 33.0 | Net Profit Margin | 10.0 | Low | 515.25 |
The current prices are delayed, login to your account to see live prices.
LOGIN
Performance
Today’s Low
Today’s High
515.25
529.55
52W Low
52W High
303.55
706
| Open Price | 527.95 | Volume | 1 |
| Prev. Close | 527.95 |
Fundamentals
| Market Cap | 536 Cr | ROE | 53.5% | ||
| P/E Ratio(TTM) | 33.0 | EPS(TTM) | 0.0 | ||
| P/B Ratio | 6.3 | Dividend Yield | 0.1% | ||
| Industry P/E | 151.4 | Book Value | 83.2 | ||
| Face Value | 10.0 |
About the Company
Balaxi Pharmaceuticals Limited is a branded IPR-based pharmaceutical Company focusing on frontier markets, with a vast and growing portfolio of drugs across multiple therapeutic segments. Its markets extend across the continents of Americas, Africa and the Caribbean islands. It is a dynamic and responsible company, with a rich and growing portfolio of branded and generic medicines and consumer products.
Business area of the company
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products
History and Milestones
2003-07
- Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.
- Sourcing was from WHO GMP certified plants based in India.
2008-10
- Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
2011-13
- Started sourcing pharmaceutical from WHO GMP certified manufacturers in China by setting up an office in China in 2011.
- Opened first wholesale depot for its ancillary business in Angola.
2014-16
- In 2014, the group expanded its pharmaceutical business in Angola by setting up its 12th wholesale depot and a central distribution warehouse.
- Made in-roads in Dominican Republic pharmaceutical market, submitted technical dossiers for securing product registrations and opened a central distribution warehouse.
2017-19
- Set-up central distribution warehouse in Guatemala marking the entry of Balaxi into its third geography.
- Leveraged the vast on-ground infrastructure in Angola by entering branded consumer goods products business in 2019.
2020
- Submitted several technical dossiers of Pharmaceutical products in EL Salvador and Honduras for product registrations.
| Parent Organization | Balaxi Pharmaceuticals Ltd. | Managing Director | Ashish Maheshwari | ||
| Founded | 1942 | NSE Symbol | BALAXI |
Financials
All values are in Rs Cr
Shareholding Pattern
Promoters
72.86%
Mutual Funds
0.00%
Foreign Institutions
19.28%
Domestic Institutions
0.03%
Promoters
72.86%
Mutual Funds
0.00%
Foreign Institutions
19.28%
Domestic Institutions
0.03%
Promoters
72.86%
Mutual Funds
0.00%
Foreign Institutions
19.28%
Domestic Institutions
0.03%
Promoters
72.86%
Mutual Funds
0.00%
Foreign Institutions
19.28%
Domestic Institutions
0.03%
Promoters
72.86%
Mutual Funds
0.00%
Foreign Institutions
19.28%
Domestic Institutions
0.03%
Peer Comparison
| Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
|---|---|---|---|---|---|
527.95(0.0%) | 33.0 | ||||
429.1(0.3%) | 27.6 | ||||
275.05(0.0%) | 13.3 | ||||
78.9(0.6%) | 14.1 |
Recently Viewed
Frequently asked questions
You can buy the shares of Balaxi Pharma using the Trinkerr Website or by downloading the Trinkerr app from Android and Apptore.
